BALAXI PHARMACEUTICALS LIMITED
BALAXI
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 202616
Quarter ₹ crore YoY Jun 2024 19 -24.0% Sept 2024 21 +27.8% Dec 2024 11 -12.1% Mar 2025 10 -39.3% Jun 2025 17 -12.2% Sept 2025 19 -8.7% Dec 2025 25 +120.4% Mar 2026 20 +109.8% Jun 2026 16 -6.7% - ₹ crore
Jun 20260.92
Quarter ₹ crore Jun 2024 0.85 Sept 2024 1 Dec 2024 3 Mar 2025 0.32 Jun 2025 0.46 Sept 2025 4 Dec 2025 2 Mar 2026 3 Jun 2026 0.92 - ₹ crore
Jun 202616
Quarter ₹ crore Jun 2024 20 Sept 2024 22 Dec 2024 14 Mar 2025 10 Jun 2025 17 Sept 2025 24 Dec 2025 26 Mar 2026 24 Jun 2026 16 - Cost structure
- ₹ crore
Jun 20262
Quarter ₹ crore Jun 2024 1 Sept 2024 1 Dec 2024 1 Mar 2025 1 Jun 2025 1 Sept 2025 1 Dec 2025 1 Mar 2026 2 Jun 2026 2 - ₹ crore
Jun 202618
Quarter ₹ crore Jun 2024 18 Sept 2024 20 Dec 2024 12 Mar 2025 11 Jun 2025 17 Sept 2025 19 Dec 2025 24 Mar 2026 23 Jun 2026 18 - Exceptional items and tax
- ₹ crore
Jun 2026-1
Quarter ₹ crore Jun 2024 2 Sept 2024 2 Dec 2024 2 Mar 2025 -1 Jun 2025 0.26 Sept 2025 4 Dec 2025 2 Mar 2026 0.41 Jun 2026 -1 - ₹ crore
Jun 20260.14
Quarter ₹ crore Jun 2024 0.51 Sept 2024 0.54 Dec 2024 0.59 Mar 2025 0.04 Jun 2025 0.06 Sept 2025 0.98 Dec 2025 0.59 Mar 2026 0.26 Jun 2026 0.14 - Profit
- ₹ crore
Jun 2026-1
Quarter ₹ crore YoY Jun 2024 1 -46.1% Sept 2024 2 +40.5% Dec 2024 2 +257.1% Mar 2025 -1 -104.9%* Jun 2025 0.19 -85.8% Sept 2025 3 +96.4% Dec 2025 2 -12.2% Mar 2026 0.16 +113.4%* Jun 2026 -1 -743.0% - Per share
- ₹ per share
Jun 2026-0.23
Quarter ₹ per share Jun 2024 0.25 Sept 2024 0.30 Dec 2024 0.32 Mar 2025 -0.21 Jun 2025 0.04 Sept 2025 0.59 Dec 2025 0.28 Mar 2026 0.03 Jun 2026 -0.23 - Leverage
Debt to equity
timesJun 20240.00x
Quarter times Jun 2024 0.00x Sept 2024 — Dec 2024 — Mar 2025 — Jun 2025 — Sept 2025 — Dec 2025 — Mar 2026 — Jun 2026 —
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 19 | 21 | 11 | 10 | 17 | 19 | 25 | 20 | 16 | |
| Revenue YoY | -24.0% | +27.8% | -12.1% | -39.3% | -12.2% | -8.7% | +120.4% | +109.8% | -6.7% |
| 0.85 | 1 | 3 | 0.32 | 0.46 | 4 | 2 | 3 | 0.92 | |
| 20 | 22 | 14 | 10 | 17 | 24 | 26 | 24 | 16 | |
| Cost structure | |||||||||
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |
| 18 | 20 | 12 | 11 | 17 | 19 | 24 | 23 | 18 | |
| Exceptional items and tax | |||||||||
| 2 | 2 | 2 | -1 | 0.26 | 4 | 2 | 0.41 | -1 | |
| 0.51 | 0.54 | 0.59 | 0.04 | 0.06 | 0.98 | 0.59 | 0.26 | 0.14 | |
| Profit | |||||||||
| 1 | 2 | 2 | -1 | 0.19 | 3 | 2 | 0.16 | -1 | |
| Net profit YoY | -46.1% | +40.5% | +257.1% | -104.9%* | -85.8% | +96.4% | -12.2% | +113.4%* | -743.0% |
| Per share | |||||||||
| 0.25 | 0.30 | 0.32 | -0.21 | 0.04 | 0.59 | 0.28 | 0.03 | -0.23 | |
| Leverage | |||||||||
| Debt to equity | 0.00x | — | — | — | — | — | — | — | — |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.